What You Should Know
- Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for "decoding" female biology.
- Led by Precursor Ventures, the company is pioneering a first-of-its-kind diagnostic platform that combines menstrual fluid analysis with peripheral blood and AI-powered multi-omics to identify the root causes of chronic conditions like endometriosis, PCOS, and perimenopause.
The Biological Signal: Tapping Into Menstrual
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences
What You Should Know
- Anthropic has officially launched Claude for Healthcare, a suite of HIPAA-ready tools that allow providers and payers to use its latest model, Opus 4.5, for high-stakes medical tasks like prior authorization and claims appeals.
- Simultaneously, the company has significantly expanded Claude for Life Sciences, adding deep integrations with platforms like Medidata and ClinicalTrials.gov to automate clinical trial operations and regulatory submissions.
The Engine:
Read More
Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI
What You Should Know
- Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
- Unlike traditional AI that focuses on discovering new molecules, Allos targets the "formulation gap"—applying causal modeling to existing complex generics and next-generation medicines to improve their tolerability, bioavailability, and long-term patient outcomes.
The Problem: The
Read More
Penguin Ai Launches Snowflake Native App to Automate HCC Risk Adjustment
What You Should Know
- Penguin Ai has announced the launch of its Hierarchical Condition Category (HCC) Coding & Risk Adjustment solution as a Snowflake Native App.
- By bringing its risk-adjustment intelligence directly into a customer’s Snowflake environment, Penguin Ai enables Medicare Advantage (MA) plans and risk-bearing providers to automate diagnosis extraction and improve Risk-Adjustment Factor (RAF) accuracy without moving or exposing sensitive patient data.
The "Data
Read More
HealthEx and Anthropic Partner to Bring Personal Health Records Directly to Claude
What You Should Know
- HealthEx and Anthropic have launched a first-of-its-kind integration that allows Claude Pro and Max users to securely connect their medical records from over 50,000 provider organizations directly to the AI.
- The partnership leverages the federal TEFCA framework and a new Model Context Protocol (MCP) to provide personalized health summaries and lab interpretations while ensuring that sensitive patient data is never used for model training.
Bridging the
Read More
Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics
What You Should Know
- Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
- The partnership includes the development of an exclusive, purpose-built AI model trained on Lilly’s proprietary data, leveraging Chai's Chai-2 platform to compress discovery timelines from months to weeks.
The "Zero-Shot" Revolution: Slashing Discovery Timelines
In the world of biologics, antibody design has
Read More
DiMe Launches Initiative to Scale Trusted AI Care Navigation
What You Should Know
- The Digital Medicine Society (DiMe) has launched a new multi-stakeholder initiative, "Scaling Trusted, High-Impact AI Care Navigation," to accelerate the responsible adoption of AI tools that help patients manage appointments, referrals, and insurance.
- Led by title sponsor Intel and a founding coalition of tech and healthcare leaders, the project will develop open-access resources to ensure AI-enabled care journeys are patient-centered, equitable, and
Read More
The GPT-5 Era: OpenAI Launches ‘OpenAI for Healthcare’ and GPT-5.2 to Power the Modern Hospital
What You Should Know
- OpenAI has officially entered the medical market with OpenAI for Healthcare, a suite of products led by ChatGPT for Healthcare and the GPT-5.2-powered API.
- Already rolling out to eight leading institutions—including Stanford Medicine, HCA Healthcare, and UCSF—the platform provides a secure, HIPAA-compliant workspace for clinical reasoning, evidence retrieval with transparent citations, and the automation of administrative tasks like prior authorizations and
Read More
The 40% Difference: Why AI Must Anchor Your RCM Modernization Strategy in 2026
The Crisis Facing Healthcare Financial Leaders
Healthcare financial leaders are navigating an environment of unprecedented complexity. Your organization is caught between escalating operational costs and a relentless denial rate fueled by increasingly sophisticated payer tactics. The truth is, if your Revenue Cycle Management (RCM) is reliant on manual, legacy systems, you are accepting a permanent, self-inflicted fiscal vulnerability.
Industry data confirms this exposure: upwards of 10%
Read More
